Catalyst Wire Dossier Catalyst Wire Dossier

PEG3350-based gut cleansing solution (low-volume, split-dose)

polyethylene glycol 3350 · Norgine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEG3350-based gut cleansing solution (low-volume, split-dose), covering 2013-04-18 to 2013-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects [Phase 1]

See pricing